Dust mite-derived Enterobacterial fimbriae H protein enforces the allergen specific immunotherapy in asthma mice

X Yang1, H Wang2, D Zhao3

  • 1State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China; Shenzhen Luohu Maternity and Child Healthcare Hospital, #2013 Taibai Road, Shenzhen, 518019, China.

Abstract

Insights

Enterobacterial fimbriae H (FimH) protein enhances immunotherapy for asthma in mice. FimH boosts regulatory T cells (Tregs) and improves allergic responses, offering a novel therapeutic strategy for asthma.

Area of Science:

  • Immunology
  • Microbiology
  • Allergy Research

Background:

  • Dust mite microbiota produce microbial products that can act as immune adjuvants.
  • Bacterial proteins, including Enterobacterial fimbriae H (FimH), are found in dust mites.

Purpose of the Study:

  • To investigate the potential of FimH as an adjuvant to enhance allergen-specific immunotherapy (ASIT) in a mouse model of asthma.
  • To determine if FimH can improve the efficacy of ASIT by modulating immune responses.

Main Methods:

  • Asthmatic mice were treated with ASIT using recombinant Der f1/f2 allergens, with or without FimH.
  • Evaluated changes in inflammatory cell infiltration, airway hyperreactivity, regulatory T cell (Treg) frequency, specific immune cell populations (CD4+IFN-γ+, CD4+IL-4+), and serum cytokine levels (TGF-β, IL-10, IL-13, IL-17A).
  • In vitro studies assessed FimH's effect on IL-10 expression and Treg differentiation.

Main Results:

  • ASIT combined with FimH significantly reduced airway inflammation, hyperreactivity, and specific IgE/IgG1 levels compared to ASIT alone.
  • FimH treatment increased Treg frequency, CD4+IFN-γ+ cells, and serum TGF-β and IL-10 levels, while decreasing CD4+IL-4+ cells and IL-13/IL-17A levels.
  • In vitro, FimH induced IL-10 production in a dose-dependent manner and promoted Treg differentiation.

Conclusions:

  • FimH acts as an effective adjuvant, enhancing the therapeutic effects of ASIT in asthmatic mice.
  • The mechanism involves augmenting regulatory T cells (Tregs), leading to improved immune tolerance and reduced allergic inflammation.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Allergic Reactions02:06

Allergic Reactions

Overview
31.7K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.0K